alexa The VCG Platform Facilitates Mucosal And Systemic Vaccine Delivery For Induction Of Protective Immunity In The Female Genital Tract | 62889
ISSN: 2157-7560

Journal of Vaccines & Vaccination
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

15th Annual Summit on Vaccines and Immunization

Francis Eko
Morehouse School of Medicine, USA
Keynote: J Vaccines Vaccin
DOI: 10.4172/2157-7560.C1.053
Abstract
Statement of the Problem: The delivery vehicle and route of vaccine administration play an important role in the induction of optimal immune effectors and their homing to the site of infection to achieve protective immunity. The choice of an adequate route of vaccine administration is desirable to avoid compromising a potentially efficacious vaccine. We have designed a versatile Vibrio cholerae ghost (VCG) platform, an effective self-adjuvanting delivery vehicle capable of simultaneously delivering multiple vaccine antigens from the same or different pathogens to the immune system. It offers an attractive approach for developing vaccines against a number of human pathogens. The present study was undertaken to compare the potential of rectal mucosal and intramuscular systemic immunizations for induction of female genital tract immunity in mice using a VCG-based chlamydial vaccine. Methodology & Theoretical Orientation: Groups of mice were immunized rectally (IR) or intramuscularly (IM) with VCG expressing the Chlamydia trachomatis porin B and polymorphic membrane protein D proteins (rVCG-PmpD/PorB; PmpDvac) or glycoprotein D from HSV-2 (rVCG-gD2 or gD2) as antigen control. Vaccine efficacy was assessed by evaluating the intensity and duration of genital chlamydial shedding following intra-vaginal challenge with live chlamydiae. Analysis of variance (ANOVA) was used to compare differences between groups. Results: We demonstrated that both IM and IR immunization of mice with PmpD-vac elicited high levels of antigen-specific Th1 cell-mediated and humoral immune responses in mucosal and systemic tissues. Also, immunization reduced the length and intensity of genital chlamydial shedding following intra-vaginal challenge with live chlamydiae, irrespective of route of vaccine administration. Conclusion & Significance: These results highlight the potential of the VCG platform for eliciting immunity in the female genital tract via both mucosal and systemic delivery of antigens in the absence of external adjuvants.
Biography

Francis Eko is a Professor of Microbiology and Immunology at Morehouse School of Medicine, Atlanta (USA). His expertise is in “The development of vaccines and vaccine adjuvants”. His current research involves development of self-adjuvanting vaccines against chlamydia genital and respiratory infections and the effect of VCG-based adjuvants on immune responses to mucosal and systemic vaccines.

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]online.com

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7